Literature DB >> 26497280

Untangling a role for tau in synucleinopathies.

Marion Delenclos1, Simon Moussaud1, Pamela J McLean2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26497280      PMCID： PMC5127588          DOI： 10.1016/j.biopsych.2015.08.020

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

1.  Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.

Authors:  Urmi Sengupta; Marcos J Guerrero-Muñoz; Diana L Castillo-Carranza; Cristian A Lasagna-Reeves; Julia E Gerson; Adriana A Paulucci-Holthauzen; Shashirekha Krishnamurthy; Malika Farhed; George R Jackson; Rakez Kayed
Journal:  Biol Psychiatry       Date:  2015-01-09       Impact factor: 13.382

2.  Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.

Authors:  Yuri Trembath; Carolyn Rosenberg; John F Ervin; Donald E Schmechel; Perry Gaskell; Margaret Pericak-Vance; Jeffery Vance; Christine M Hulette
Journal:  Acta Neuropathol       Date:  2003-02-11       Impact factor: 17.088

3.  Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

4.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

5.  alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.

Authors:  P H Jensen; H Hager; M S Nielsen; P Hojrup; J Gliemann; R Jakes
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

6.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

7.  Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Authors:  Todd L Edwards; William K Scott; Cherylyn Almonte; Amber Burt; Eric H Powell; Gary W Beecham; Liyong Wang; Stephan Züchner; Ioanna Konidari; Gaofeng Wang; Carlos Singer; Fatta Nahab; Burton Scott; Jeffrey M Stajich; Margaret Pericak-Vance; Jonathan Haines; Jeffery M Vance; Eden R Martin
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

8.  Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

9.  Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level.

Authors:  Georg Nübling; Benedikt Bader; Johannes Levin; Jenna Hildebrandt; Hans Kretzschmar; Armin Giese
Journal:  Mol Neurodegener       Date:  2012-07-23       Impact factor: 14.195

Review 10.  Alpha-synuclein and tau: teammates in neurodegeneration?

Authors:  Simon Moussaud; Daryl R Jones; Elisabeth L Moussaud-Lamodière; Marion Delenclos; Owen A Ross; Pamela J McLean
Journal:  Mol Neurodegener       Date:  2014-10-29       Impact factor: 14.195
  10 in total
  2 in total

1.  Investigating key factors underlying neurodegeneration linked to alpha-synuclein spread.

Authors:  Cindy C C Pang; Maja H Sørensen; Krit Lee; Kelvin C Luk; John Q Trojanowski; Virginia M Y Lee; Wendy Noble; Raymond C C Chang
Journal:  Neuropathol Appl Neurobiol       Date:  2022-07-04       Impact factor: 6.250

2.  A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo.

Authors:  Marion Delenclos; Teodora Trendafilova; Daryl R Jones; Simon Moussaud; Ann-Marie Baine; Mei Yue; Warren D Hirst; Pamela J McLean
Journal:  Front Neurosci       Date:  2016-01-19       Impact factor: 4.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.